Venus Remedies Limited — Others, 23-08-2025: Shareholders meeting

Venus Remedies announced that all resolutions at its 36th Annual General Meeting were approved by shareholders. This includes the adoption of the audited standalone and consolidated financial statements for the financial year ended March 31, 2025. Shareholders also approved the re-appointment of Mr. Akshansh Chaudhary as a director. Key leadership re-appointments were cleared: Mr. Pawan Chaudhary as MD, Mr. Peeyush Jain as Dy. MD, Mr. Ashutosh Jain and Mr. Akshansh Chaudhary as Executive Directors, each for five years. Mr. Navdeep Sud was re-appointed as an Independent Director for a second term. The remuneration of cost auditors for FY2025-26 at Rs. 1,10,000 was ratified.